Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.560 | Biomarker | disease | BEFREE | MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells. | 27918099 | 2017 | ||||
|
0.560 | GeneticVariation | disease | BEFREE | Potential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in Taiwan. | 21789902 | 2011 | ||||
|
0.560 | GeneticVariation | disease | BEFREE | However, there was no association of p53 or CCND1 polymorphisms with UC risk. | 18640142 | 2008 | ||||
|
0.560 | Biomarker | disease | RGD | Deregulation of the p16-cyclin D1/cyclin-dependent kinase 4-retinoblastoma pathway involved in the rat bladder carcinogenesis induced by terephthalic acid-calculi. | 16896691 | 2006 | ||||
|
0.560 | Biomarker | disease | BEFREE | Amplification of CCND1 or alterations in c-myc/CCND1 early in bladder cancer may have clinical relevance in promoting and predicting progression to detrusor-muscle-invasive transitional cell carcinoma. | 12237776 | 2002 | ||||
|
0.560 | AlteredExpression | disease | BEFREE | Tissue samples from 67 patients with transitional cell carcinoma were examined with an immunohistochemical stain for the expression of p16 and cyclin D1 genes. | 12372886 | 2002 | ||||
|
0.560 | Biomarker | disease | LHGDN | Amplification of CCND1 or alterations in c-myc/CCND1 early in bladder cancer may have clinical relevance in promoting and predicting progression to detrusor-muscle-invasive transitional cell carcinoma. | 12237776 | 2002 | ||||
|
0.560 | Biomarker | disease | CTD_human | Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. | 12151359 | 2002 | ||||
|
0.560 | AlteredExpression | disease | BEFREE | We analysed the expression of cyclin D1 in 75 patients with transitional cell carcinoma (TCC) to investigate the possible relationship between its expression and clinical outcome as well as histopathological findings using the immunohistochemical method. | 9192983 | 1997 |